Philip D. Dunne

12.9k citations

71 papers · 6.1k indexed · 1 hit paper · h-index 22

Biophysics top 0.5%
Oncology top 1%
- Colorectal Cancer Treatments and Studies 16
- Cancer Immunotherapy and Biomarkers 10
- Colorectal Cancer Surgical Treatments 9
- Colorectal Cancer Screening and Detection 6
- Cancer Cells and Metastasis 5
Cancer Research top 2%
Immunology top 2%
Pathology and Forensic Medicine top 2%
- Genetic factors in colorectal cancer 16
Molecular Biology
- Bioinformatics and Genomic Networks 7
Radiology, Nuclear Medicine and Imaging
- Radiomics and Machine Learning in Medical Imaging 6

Co-authors: Manuel Salto‐Tellez Darragh G. McArt Maurice B. Loughrey Peter W. Hamilton Helen G. Coleman Stephen McQuaid Peter Bankhead Jacqueline A. James
Cited by: Biophysics Oncology Cancer Research
Journals: Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)
Partner nations: United Kingdom United States Ireland

In The Last Decade

Philip D. Dunne

68 papers receiving 6.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Philip D. Dunne

Since Specialization

Citations

This map shows the geographic impact of Philip D. Dunne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Dunne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Dunne more than expected).

Fields of papers citing papers by Philip D. Dunne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. Dunne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Dunne. The network helps show where Philip D. Dunne may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Philip D. Dunne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip D. Dunne Line = papers co-authored together Philip D. Dunne links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy npj Precision Oncology ·Maxime W. Lafarge,Enric Domingo,Korsuk Sirinukunwattana,Ruby Wood,Leslie Samuel,Graeme I. Murray,Susan D. Richman,Andrew Blake,David Sebag‐Montefiore,Simon Gollins,E. Klieser,Daniel Neureiter,Florian Huemer,Richard Greil,Philip D. Dunne,Philip Quirke,Lukas Weiß,Jens Rittscher,Tim Maughan,Viktor H. Koelzer	2024	9
2	Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data Disease Models & Mechanisms ·Baharak Ahmaderaghi,Raheleh Amirkhah,James G. Jackson,Tamsin R.M. Lannagan,Kathryn Gilroy,Sudhir B. Malla,Keara L. Redmond,Gerard P. Quinn,Simon S. McDade,Tim Maughan,Simon J. Leedham,Andrew D. Campbell,Owen J. Sansom,Mark Lawler,Philip D. Dunne	2022	3
3	Tumour invasion and dissemination Biochemical Society Transactions ·Ryan Lusby,Philip D. Dunne,Vijay Tiwari	2022	18
4	Development of a semi‐automated method for tumour budding assessment in colorectal cancer and comparison with manual methods Histopathology ·Natalie C. Fisher,Maurice B. Loughrey,Helen G. Coleman,Melvin D Gelbard,Peter Bankhead,Philip D. Dunne	2021	13
5	Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer Molecular Cancer Therapeutics ·Nyree Crawford,Katie J. Stott,Tamas Sessler,Christopher McCann,William J. McDaid,Andrea Lees,Cheryl H. Latimer,Jennifer Fox,Joanne M. Munck,Tomoko Smyth,Alpesh Shah,Vanessa Martins,Mark Lawler,Philip D. Dunne,Emma Kerr,Simon S. McDade,Vicky M. Coyle,Daniel B. Longley	2021	21
6	Downregulation of PPARα during Experimental Left Ventricular Hypertrophy is Critically Dependent on Nox2 NADPH Oxidase Signalling International Journal of Molecular Sciences ·Adam Harvey,Emma Robinson,Kevin Edgar,Ross McMullan,K. O'Neill,Matthew Alderdice,Raheleh Amirkhah,Philip D. Dunne,Barbara J. McDermott,David Grieve	2020	12
7	ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGA Cancer Research ·Alan R. Gilmore,Matthew Alderdice,Kienan I. Savage,Paul G. O’Reilly,Aideen C. Roddy,Philip D. Dunne,Mark Lawler,Simon S. McDade,David Waugh,Darragh G. McArt	2019	6
8	The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer Cells ·Raheleh Amirkhah,Hojjat Naderi‐Meshkin,Jaynish S. Shah,Philip D. Dunne,Ulf Schmitz	2019	34
9	ATU-06 Does the timing of TIPSS in patients with acute oesophageal variceal bleeding alter patient outcome? Philip D. Dunne,Rohit Sinha,Dhiraj Tripathi,Peter Hayes	2019	3
10	Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer Cancer Immunology Research ·Grace O’Malley,Oliver Treacy,Kevin Lynch,Serika D. Naicker,Niamh Leonard,Paul Lohan,Philip D. Dunne,Thomas Ritter,Laurence J. Egan,Aideen E. Ryan	2018	68
11	Epithelial‐to‐mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition The Journal of Pathology ·Amy M.B. McCorry,Maurice B. Loughrey,Daniel B. Longley,Mark Lawler,Philip D. Dunne	2018	18
12	Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using QuPath digital image analysis Histopathology ·Maurice B. Loughrey,Peter Bankhead,Helen G. Coleman,Ryan Hagan,Stephanie G. Craig,Amy M.B. McCorry,Ronan T. Gray,Stephen McQuaid,Philip D. Dunne,Peter W. Hamilton,Jacqueline A. James,Manuel Salto‐Tellez	2018	59
13	Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies The Journal of Pathology ·Matthew Alderdice,Susan D. Richman,Simon Gollins,Peter Stewart,Chris Hurt,Richard Adams,Amy M.B. McCorry,Aideen C. Roddy,Dale Vimalachandran,Claudio Isella,Enzo Médico,Tim Maughan,Darragh G. McArt,Mark Lawler,Philip D. Dunne	2018	40
14	Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification Nature Communications ·Philip D. Dunne,Matthew Alderdice,Paul G. O’Reilly,Aideen C. Roddy,Amy M.B. McCorry,Susan D. Richman,Tim Maughan,Simon S. McDade,Patrick G. Johnston,Daniel B. Longley,Elaine W. Kay,Darragh G. McArt,Mark Lawler	2017	53
15	IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancer Cell Death Discovery ·Ryan Hutchinson,Helen G. Coleman,Kathy Gately,Vincent Young,Siobhan Nicholson,Robert Cummins,Elaine W. Kay,Seán O. Hynes,Philip D. Dunne,Seedevi Senevirathne,Peter W. Hamilton,Darragh G. McArt,Daniel B. Longley	2017	5
16	Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy Cancer Immunology Research ·Philip D. Dunne,Darragh G. McArt,Paul G. O’Reilly,Helen G. Coleman,Wendy L. Allen,Maurice B. Loughrey,Sandra Van Schaeybroeck,Simon S. McDade,Manuel Salto‐Tellez,Daniel B. Longley,Mark Lawler,Patrick G. Johnston	2016	31
17	Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer Clinical Cancer Research ·Philip D. Dunne,Darragh G. McArt,Conor A. Bradley,Paul G. O’Reilly,Helen L. Barrett,Robert Cummins,Tony O’Grady,Ken Arthur,Maurice B. Loughrey,Wendy L. Allen,Simon S. McDade,David Waugh,Peter W. Hamilton,Daniel B. Longley,Elaine W. Kay,Patrick G. Johnston,Mark Lawler,Manuel Salto‐Tellez,Sandra Van Schaeybroeck	2016	103
18	EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer Clinical Cancer Research ·Philip D. Dunne,Sonali Dasgupta,Jaine K. Blayney,Darragh G. McArt,Keara L. Redmond,Jessica-Anne Weir,Conor A. Bradley,Takehiko Sasazuki,Senji Shirasawa,Tingting Wang,Supriya Srivastava,Chee Wee Ong,Ken Arthur,Manuel Salto‐Tellez,Richard H. Wilson,Patrick G. Johnston,Sandra Van Schaeybroeck	2015	108
19	AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer Clinical Cancer Research ·Philip D. Dunne,Darragh G. McArt,Jaine K. Blayney,Murugan Kalimutho,Samanda Greer,Tingting Wang,Supriya Srivastava,Chee Wee Ong,Ken Arthur,Maurice B. Loughrey,Keara L. Redmond,Daniel B. Longley,Manuel Salto‐Tellez,Patrick G. Johnston,Sandra Van Schaeybroeck	2013	89
20	Pharmacogenomic Profiling and Pathway Analyses Identify MAPK-Dependent Migration as an Acute Response to SN38 in p53 Null and p53-Mutant Colorectal Cancer Cells Molecular Cancer Therapeutics ·Wendy L. Allen,Richard Turkington,Leanne Stevenson,Gail Carson,Vicky M. Coyle,Suzanne Hector,Philip D. Dunne,Sandra Van Schaeybroeck,Daniel B. Longley,Patrick G. Johnston	2012	7

About Philip D. Dunne

Philip D. Dunne is a scholar working on Oncology, Pathology and Forensic Medicine and Hepatology, having authored 71 papers that have together received 6.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Genetic factors in colorectal cancer (16 papers), Cancer Immunotherapy and Biomarkers (10 papers), Colorectal Cancer Surgical Treatments (9 papers), Bioinformatics and Genomic Networks (7 papers), Colorectal Cancer Screening and Detection (6 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Biophysics (388 citations), Oncology (1.8k citations) and Cancer Research (744 citations). Philip D. Dunne has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Manuel Salto‐Tellez, Darragh G. McArt, Maurice B. Loughrey, Peter W. Hamilton, Helen G. Coleman, Stephen McQuaid, Peter Bankhead, Jacqueline A. James, Ronan T. Gray and Liam Murray. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact